Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

THE (COST)EFFECTIVENESS OF NEOADJUVANT FOLFIRINOX VERSUS NEOADJUVANT GEMCITABINE BASED CHEMORADIOTHERAPY AND ADJUVANT GEMCITABINE FOR (BORDE… Ended

2024-516260-29-00 non-metastatic (borderline) resectable pancreatic cance 5 2024-10-10
Dose Escalation Phase 1 Study of IOA-289 in combination with gemcitabine/nab-paclitaxel Ended

2024-515674-27-00 metastatic pancreatic cancer 3 2024-10-01
A Study of HST-1011 For The Treatment Of People With Advanced Cancers That Are Not Benefiting From Other Standard of Care Therapies Ended

2023-503731-18-00 Advanced Solid Tumors 7 2024-09-30
An open label, multicenter, phase II study of belantamab mafodotin in combination with VRd for the treatment of newly diagnosed transplant e… Ended

2024-516130-35-00 Multiple myeloma 4 2024-09-26
A phase 1 study to evaluate the dose, safety and tolerability of a radionuclide therapy (Radspherin®) in patients with platinum sensitive re… Ended

2024-511851-16-00 Platinum Sensitive Recurrent Epithelial Ovarian, Fallop 1 2024-09-20
A first-in-human study to learn how safe the study treatment BAY2862789 is, to find the best dose, how it affects the body, what maximum amo… Ended

2024-510998-26-00 Advanced solid tumors 1 2024-09-18
An open label, phase 1 study to evaluate the safety, feasibility and immunogenicity of an allogeneic, cell-based vaccine (VIDIDENCEL) in hig… Ended

2024-516781-10-00 High grade serous ovarian cancer 1 2024-09-16
A safety study of PF-08046044/SGN-35C in adults with advanced cancers Ended

2023-505813-26-00 Lymphoma, Large B-Cell, Diffuse 1 2024-09-12
A Phase 1/2 Study of AMG 193 in Combination with IDE397 in Subjects with Advanced MTAP-null Solid Tumors Ended

2023-504364-42-00 In Part 1, subjects with advanced MTAP-null solid tumor 9 2024-09-12
AML-NET : Acute Myeloid Leukemia treated with with NETrin Abs in combination with [AZACITIDINE + VENETOCLAX] Ended

2023-503408-10-00 Refractory Acute Myeloïd Leukemia 9 2024-09-08
Perioperative Treatment in Resectable Gastric Cancer with Spartalizumab (PDR001) in Combination with fluorouracil, leucovorin, oxaliplatin, … Ended

2024-516299-13-00 Resectable Gastric Cancer 4 2024-09-06
CABONEN – a phase II trial of Cabozantinib in patients with advanced, low proliferative NEN G3 Ended

2024-510863-50-00 Neuroendocrine Neoplasia Neuroendocrine Tumor 4 2024-08-30
Phase Ib Clinical Trial to Evaluate the Safety Profile of the Combination Tilray FS Oral Solution T10:C10 with Temozolomide and Radiotherapy… Ended

2024-515546-16-00 Glioblastoma 3 2024-08-27
First-in-man clinical trial to assess safety and tolerability of CEB-01 PLGA membrane in patients with recurrent or locally advanced retrope… Ended

2024-516971-34-00 Recurrent or locally advanced retroperitoneal soft tiss 1 2024-08-20
Phase 2 Study of BB-1701 in HER2 positive or HER2-low metastatic breast cancer Ended

2023-506866-30-00 HER2 positive or HER2-low metastatic breast cancer 4 2024-08-19
A study to compare efficacy, safety, and immune response of GME751 and EU-authorized Keytruda in adult participants with untreated metastati… Ended

2023-506882-70-00 Non-small-cell lung cancer 5 2024-08-16
Clinical Trial Using Humanized CART Directed Against BCMA (ARI0002h) in Patients With Relapsed/Refractory Multiple Myeloma to Proteasome In… Ended

2024-515650-24-00 Multiple Myeloma 4 2024-07-26
A Study of Lorigerlimab with Docetaxel or Docetaxel Alone in Participants with Metastatic Castration-Resistant Prostate Cancer Ended

2022-502982-49-00 Metastatic Castration-Resistant Prostate Cancer 4 2024-07-15
A Study in Healthy Adult Male Participants to Evaluate the Metabolism of [14C]PF-06821497 Ended

2023-508371-36-00 small cell lung cancer (SCLC), castration resistant pro 3 2024-07-15
PRODIGE 55-SOCRATE : A randomized phase II study to evaluate second-line ramucirumab alone or with paclitaxel in older patients with advance… Ended

2024-513515-27-00 stomach cancer stage IV with metastases 4 2024-07-10
FDG-PET/CT versus conventional CT for response monitoring in metastatic breast cancer: A pilot study for a randomized clinical trial (MONITO… Ended

2023-506550-20-00 Metastatic breast cancer 10 2024-07-05
A study to compare effectiveness and safety of a combination of vudalimab or pembrolizumab with chemotherapy in participants with advanced l… Ended

2023-509644-10-00 Advanced Non-small Cell Lung Cancer 9 2024-06-27
An Open-Label Multicenter 3-Arm Randomized Phase 2 Study to Assess the Efficacy and Safety of TTX-030 and Chemotherapy With or Without Budig… Ended

2023-508356-19-00 Pancreatic adenocarcinoma metastatic 4 2024-06-25
A safety study of PF-08046045/SGN-35T in adults with advanced cancers Ended

2022-502390-41-00 Enteropathy-Associated T-Cell Lymphoma 1 2024-06-20